LOS ANGELES, May 20, 2008 (PRIME NEWSWIRE) -- Universal Detection Technology (www.udetection.com) (OTCBB:UDTT) (Frankfurt:PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced more than 5,000% increase in revenues for the 3 months ended March 31, 2008 compared to the same period a year ago. The full financial results are available in the Company's publicly available quarterly report.
The Company reported that during the first three months of 2008, revenues from sales of products and services reached $60,000.
The Company had significant sales of its biological detection kits to both domestic and international clients. One of the major orders for the Company's handheld assays was from the Washington D.C. Fire and Emergency Services. The Company also had increased the sale of its radiological and nuclear detection devices to both domestic and international customers.
Additionally, the company has recognized revenues from sales of its line of anti-microbial products in particular products designed to sterilize surfaces from the deadly MRSA bacteria. The sales have come on the heels of increased reports of the spread of MRSA beyond hospitals to schools and assisted care facilities.
"The first quarter of 2008 was a period when we started recognizing revenues from sales of our diverse range of products and services. We not only generated significant interest in our handheld assays used for rapid detection of multiple bioterrorism agents but also added new lines of products in areas that we saw high demand. Such products include our radiation detection systems and anti microbial products capable of killing deadly antibiotic resistant bacteria," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer. "We hope that the momentum that we have built will carry into the future and that our sales will grow as we continue to market our products and our solutions," he added.
UDTT is a supplier of services and technologies used for early detection of Chemical, Biological, Radiological, and Nuclear (CBRN) threats. The Company's BSM-2000 combines a bioaerosol capture device with a simple and robust chemical test for bacterial spores that is completely automated. The Company proposes the use of BSM-2000 as a front-end monitor to the Biohazard Detection System (BDS) or any other Secondary monitor with the promise of drastically reducing the recurring operating costs for anthrax screening at postal facilities and any other facility where bio-terrorism is of concern.
For more information please visit our website at www.udetection.com or Email us at info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain bio hazard substances. For more information, please visit http://www.udetection.com.
The Universal Detection Technology logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4911
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.